Inaugural Meeting of the International Myeloma Foundation (IMF) Asian Myeloma Network (AMN)

Share Article

Composed of myeloma experts from China, Hong Kong, Taiwan, Japan, Rep. of Korea, Singapore, and Thailand, the IMF Asian Myeloma Network- the first of its kind in the region- will take the lead in projects to assist IMF in providing physician education and patient support throughout Asia.

On March 17th the International Myeloma foundation (IMF) established the Asian Myeloma Network (AMN) at a meeting in Singapore. Composed of myeloma experts from China, Hong Kong, Taiwan, Japan, Rep. of Korea, Singapore, and Thailand, the IMF Asian Myeloma Network—the first of its kind in the region—will take the lead in projects to assist IMF in providing physician education and patient support throughout Asia. Multiple Myeloma is a growing health problem in Asia, with an incidence that is approaching that in western countries, but with a much larger population base.

The initial focus of the network will be the development of a unified database to assess the incidence of myeloma in Asian countries as a key step in designing region-specific treatment management tools and strategies. The IMF will collaborate with the AMN to establish this integrated database. Intended future projects will include the implementation of Asian clinical trials, as well as the development of informational resource materials in local languages, especially for patients and care givers. The extensive library of educational materials and publications on the IMF website will be available as a guide.

A formal yearly meeting will be held to review the Network’s progress and plan future projects; the next is scheduled for Shanghai, China in 2012.

About the International Myeloma Foundation
Founded in 1990, the IMF is the oldest and largest myeloma organization in the world, reaching more than 195,000 members in 113 countries. A 501©3 non-profit organization the IMF’s mission is to improve the quality of life of Myeloma patients while working toward prevention and a cure. The IMF focuses in four key areas: research, education, support and advocacy. The research arm of the IMF, International Myeloma Working Group (IMWG), comprised of 145 world recognized collaborative researchers, continues to lead the way in Myeloma treatment and research.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Abigail Rich
arich@myeloma.org
818-487-7455
Email >
Visit website